Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × Tyrosine Kinase Inhibitors × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 3 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Lung Neoplasms 1 Lung Diseases 1 Leukemia, Myeloid, Chronic-Phase 1 Kidney Neoplasms 1 Gastro Intestinal Stromal Tumor 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma, Bronchogenic 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡